Transglutaminase 2 enhances hepatocyte growth factor signaling to drive the mesothelioma cancer cell phenotype

Keyphrases

• Growth Factor Signaling 100%
• Mesothelioma 100%
• Hepatocyte Growth Factor 100%
• Cancer Cell Phenotype 100%
• Transglutaminase 2 100%
• ERK2 50%
• MEK1 50%
• Cancer Phenotype 37%
• Mesothelioma Cells 37%
• Tumor 25%
• MET Signaling 25%
• Spheroid Formation 25%
• Protein Level 12%
• MRNA Level 12%
• Receptor Signaling 12%
• Cell Survival 12%
• Small Tumor 12%
• Messenger RNA (mRNA) 12%
• Tyrosine Kinase Activity 12%
• Survival Proteins 12%
• Cancer Cell Survival 12%
• Genetic Method 12%
• MET Inhibitor 12%
• Cancer Spheroids 12%
• Genetic Treatment 12%
• MET Receptor 12%

Medicine and Dentistry

• Cancer Cell 100%
• Mesothelioma 100%
• Scatter Factor 100%
• Protein Glutamine Gamma Glutamyltransferase 2 100%
• Mitogen Activated Protein Kinase 3 50%
• Malignant Neoplasm 37%
• Tumor 37%
• Cell Survival 25%
• Tumor Spheroid 25%
• Messenger RNA 12%
• Mediator 12%
• Protein Tyrosine Kinase 12%
• Drive 12%
• Scatter Factor Receptor 12%

Biochemistry, Genetics and Molecular Biology

• Cancer Cell 100%
• Hepatocyte Growth Factor 100%
• Transglutaminase 100%
• Growth Factor Signaling 100%
• Cell Survival 25%
• Tumor Spheroid 25%
• Messenger RNA 12%
• Genetics 12%
• Wild Type 12%
• Mediator 12%
• Receptor Tyrosine Kinase 12%
• Tyrosine Kinase 12%
• Drive 12%